126 related articles for article (PubMed ID: 22544924)
21. Bone marrow-derived versus parenchymal sources of inducible nitric oxide synthase in experimental autoimmune encephalomyelitis.
Zehntner SP; Bourbonniere L; Hassan-Zahraee M; Tran E; Owens T
J Neuroimmunol; 2004 May; 150(1-2):70-9. PubMed ID: 15081250
[TBL] [Abstract][Full Text] [Related]
22. Taurine chloramine inhibits NO and TNF-α production in zymosan plus interferon-γ activated RAW 264.7 cells.
Kim BS; Cho IS; Park SY; Schuller-Levis G; Levis W; Park E
J Drugs Dermatol; 2011 Jun; 10(6):659-65. PubMed ID: 21637907
[TBL] [Abstract][Full Text] [Related]
23. Regulation of inducible nitric oxide synthase messenger RNA expression and nitric oxide production by lipopolysaccharide in vivo: the roles of macrophages, endogenous IFN-gamma, and TNF receptor-1-mediated signaling.
Salkowski CA; Detore G; McNally R; van Rooijen N; Vogel SN
J Immunol; 1997 Jan; 158(2):905-12. PubMed ID: 8993010
[TBL] [Abstract][Full Text] [Related]
24. The equilibrium between long and very long chain ceramides is important for the fate of the cell and can be influenced by co-expression of CerS.
Hartmann D; Wegner MS; Wanger RA; Ferreirós N; Schreiber Y; Lucks J; Schiffmann S; Geisslinger G; Grösch S
Int J Biochem Cell Biol; 2013 Jul; 45(7):1195-203. PubMed ID: 23538298
[TBL] [Abstract][Full Text] [Related]
25. Lipopolysaccharide and ceramide use divergent signaling pathways to induce cell death in murine macrophages.
Lakics V; Vogel SN
J Immunol; 1998 Sep; 161(5):2490-500. PubMed ID: 9725248
[TBL] [Abstract][Full Text] [Related]
26. Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis.
Noorbakhsh F; Tsutsui S; Vergnolle N; Boven LA; Shariat N; Vodjgani M; Warren KG; Andrade-Gordon P; Hollenberg MD; Power C
J Exp Med; 2006 Feb; 203(2):425-35. PubMed ID: 16476770
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of nitric oxide synthase for treatment of experimental autoimmune encephalomyelitis.
Brenner T; Brocke S; Szafer F; Sobel RA; Parkinson JF; Perez DH; Steinman L
J Immunol; 1997 Mar; 158(6):2940-6. PubMed ID: 9058833
[TBL] [Abstract][Full Text] [Related]
28. Role of IL-12 in macrophage activation during intracellular infection: IL-12 and mycobacteria synergistically release TNF-alpha and nitric oxide from macrophages via IFN-gamma induction.
Xing Z; Zganiacz A; Santosuosso M
J Leukoc Biol; 2000 Dec; 68(6):897-902. PubMed ID: 11129658
[TBL] [Abstract][Full Text] [Related]
29. Experimental autoimmune encephalomyelitis is exacerbated in mice lacking the NOS2 gene.
Fenyk-Melody JE; Garrison AE; Brunnert SR; Weidner JR; Shen F; Shelton BA; Mudgett JS
J Immunol; 1998 Mar; 160(6):2940-6. PubMed ID: 9510198
[TBL] [Abstract][Full Text] [Related]
30. Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice.
Tran EH; Hoekstra K; van Rooijen N; Dijkstra CD; Owens T
J Immunol; 1998 Oct; 161(7):3767-75. PubMed ID: 9759903
[TBL] [Abstract][Full Text] [Related]
31. Migration inhibitory factor induces killing of Leishmania major by macrophages: dependence on reactive nitrogen intermediates and endogenous TNF-alpha.
Jüttner S; Bernhagen J; Metz CN; Röllinghoff M; Bucala R; Gessner A
J Immunol; 1998 Sep; 161(5):2383-90. PubMed ID: 9725234
[TBL] [Abstract][Full Text] [Related]
32. Nitric oxide and TNFalpha effects in experimental autoimmune encephalomyelitis demyelination.
Farias AS; de la Hoz C; Castro FR; Oliveira EC; Ribeiro dos Reis JR; Silva JS; Langone F; Santos LM
Neuroimmunomodulation; 2007; 14(1):32-8. PubMed ID: 17700038
[TBL] [Abstract][Full Text] [Related]
33. Effect of selective IL-6 inhibitor Am-80 on experimental autoimmune encephalomyelitis in DA rats.
Wang T; Nagai H; Bouda K; Matsuura S; Takaoka Y; Niwa S; Homma T; Tanaka H; Shudo K
Acta Pharmacol Sin; 2000 Nov; 21(11):967-76. PubMed ID: 11501064
[TBL] [Abstract][Full Text] [Related]
34. The effect of gammadelta T cell depletion on cytokine gene expression in experimental allergic encephalomyelitis.
Rajan AJ; Klein JD; Brosnan CF
J Immunol; 1998 Jun; 160(12):5955-62. PubMed ID: 9637509
[TBL] [Abstract][Full Text] [Related]
35. Immunomodulatory effects of licochalcone A on experimental autoimmune encephalomyelitis.
Fontes LB; Dos Santos Dias D; de Carvalho LS; Mesquita HL; da Silva Reis L; Dias AT; Da Silva Filho AA; do Amaral Corrêa JO
J Pharm Pharmacol; 2014 Jun; 66(6):886-94. PubMed ID: 24447171
[TBL] [Abstract][Full Text] [Related]
36. Mediation of inflammation by encephalitogenic cells: interferon gamma induction of nitric oxide synthase and cyclooxygenase 2.
Misko TP; Trotter JL; Cross AH
J Neuroimmunol; 1995 Sep; 61(2):195-204. PubMed ID: 7593555
[TBL] [Abstract][Full Text] [Related]
37. Apolipoprotein E-derived peptides ameliorate clinical disability and inflammatory infiltrates into the spinal cord in a murine model of multiple sclerosis.
Li FQ; Sempowski GD; McKenna SE; Laskowitz DT; Colton CA; Vitek MP
J Pharmacol Exp Ther; 2006 Sep; 318(3):956-65. PubMed ID: 16740622
[TBL] [Abstract][Full Text] [Related]
38. The iNOS Activity During an Immune Response Controls the CNS Pathology in Experimental Autoimmune Encephalomyelitis.
Sonar SA; Lal G
Front Immunol; 2019; 10():710. PubMed ID: 31019516
[TBL] [Abstract][Full Text] [Related]
39. Expression of the inducible isoform of nitric oxide synthase in the central nervous system of mice correlates with the severity of actively induced experimental allergic encephalomyelitis.
Okuda Y; Nakatsuji Y; Fujimura H; Esumi H; Ogura T; Yanagihara T; Sakoda S
J Neuroimmunol; 1995 Oct; 62(1):103-12. PubMed ID: 7499486
[TBL] [Abstract][Full Text] [Related]
40. Critical role for PDE4 subfamilies in the development of experimental autoimmune encephalomyelitis.
Sanabra C; Johansson EM; Mengod G
J Chem Neuroanat; 2013 Jan; 47():96-105. PubMed ID: 23274837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
